Company / Income Tax
Kymera Therapeutics, Inc. Income Tax History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
-
FY2025
5-year range
$0 / $0
FY2021-FY2025
Trend
-
vs FY2024
Sector context
#120 of 204
Health Care
What the data says
Remained stable around $0 over the past 4 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#85 of 204 in Health CareTop 41% of 204
▼
Company context
Key Data Points
- Altman Z-Score 3.27 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0 | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $0 | - |
| FY2021 | $0 | - |
| FY2020 | $0 | - |
| FY2019 | $0 | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 30, 2026